You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: Diabetes
25 July 2024 - US-based M8 Pharmaceuticals, an Acino company, announced on Wednesday that it has entered into an exclusive licensing and distribution agreement with South Korea-based LG Chem Ltd.The a...
23 July 2024 - Swedish clinical-stage diabetes company Diamyd Medical (STO:DMYD-B) announced on Tuesday that it has received positive feedback from the US Food and Drug Administration (FDA) about an A...
23 July 2024 - StimAire, a US-based injectable neuromodulation company developing medical devices for obstructive sleep apnoea (OSA), announced on Monday that it has named Arthur Rascon as its new chi...
22 July 2024 - Clinical-stage biotechnology company TME Pharma N.V. (Euronext Growth Paris: ALTME) announced on Monday a strategic plan to externalise and monetise its second clinical-stage asset, NOX...
22 July 2024 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company, announced on Sunday that it has met the primary endpoint and all key secondary endpoints in the second p...
19 July 2024 - Swedish clinical-stage diabetes company Diamyd Medical AB (STO:DMYD-B) announced on Thursday that it has received Fast Track designation from the US Food and Drug Administration (FDA) f...
Related Headlines
Eluminex Biosciences doses first patient in EB 105 phase 1b Lotus trial in Diabetic Macular Edema
Novo Nordisk receives FDA response letter for once-weekly basal insulin icodec
Genentech gains FDA approval for Vabysmo prefilled syringe in treating causes of vision loss
WHO issues alert over fake copies of Novo Nordisk's weight-loss drugs
Biocon seeking partner to test semaglutide generics in China